Intellectual Property India Publishes Patent Application for Edaravone Suspension For Oral Administration

MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202548072847 A) filed by Tanabe Pharma Corporation on July 31, 2025, for Edaravone Suspension For Oral Administration.

Inventors include Hayama, Tetsuo; Takahashi, Tomohiro; Omura, Tomoyuki; Hayashi, Kouji; Matsuda, Munetomo; and Miyazawa, Tadashi Number.

The application for the patent was published on July 10, 2026, under issue no. 28/2026.

Abstract: ABSTRACT EDARAVONE SUSPENSION FOR ORAL ADMINISTRATION This invention provides with an edaravone suspension for oral administration having excellent bioavailability. It is expected that burden on ALS patients and care workers can be reduced thereby

Disclaimer: Curated by HT Syndication....